Contact Us | Log In
Search
Sensex: 33844.9 +141.30 Gold: Rs.30456.00
Nifty: 10397.5 +37.10 Silver: Rs.38195.00
Buy Cadila Healthcare, Lupin, CAPF, ITC - IndiaNotes.com
Buy Cadila Healthcare, Lupin, CAPF, ITC
Reliance Securities | Published: 12 Feb, 2018  | Source : IndiaNotes.com

Cadila Healthcare(CDH) is one of the largest domestic pharma companies in India with a strong focus on niche segment in the US market.


We assign BUY recommendation on the stock with a Target Price of Rs540 per share, based on 22x FY20E EPS of Rs24.6/share.


Positional Pick

LUPIN (LTP: 822) BUY


For today’s trade, long position can be initiated at 822-815 for target of Rs 915 with a strict stop loss of Rs 780.


Intraday Picks

CAPF (LTP: 687) BUY

For today’s trade, long position can be initiated at Rs 685-681 for target of Rs 701 with a strict stop loss of Rs 677. Traders are advised

to avoid early morning whipsaw.


ITC (LTP: 271) BUY


For today’s trade, long position can be initiated at Rs 270-267 for target of Rs 279 with a strict stop loss of Rs 265. Traders are advised

to avoid early morning whipsaw.

  Read full report Click here to read the full report


About Reliance Securities

Reliance Securities, the broking arm of Reliance Capital, is one of the India’s leading retail broking houses, providing customers with access to equities, derivatives, currency, IPOs, mutual funds, bonds, and corporate FDs amongst others. The large array of financial offerings helps customers fulfilling their investment objectives on one platform. Focus on timely & error-free execution represents its core strength. Their best in class research offerings, high degree of compliance with stock exchange regulations, ethical business standards, & strong risk management capabilities; Reliance Securities positions itself amongst strong & innovative brands in the financial services space.


For more information please write in to editor@indianotes.com


Disclaimer: The author has taken due care and caution to compile and analyse the data. The opinions expressed above are only the views of the author, and not a recommendation to buy or sell. Neither the author nor IndiaNotes.com accept any liability whatsoever arising from the use of any of the above contents.